Expression of the
p53 protein
was associated with better prognosis in patients with estrogen-negative tumors
but with a worse prognosis for estrogen-positive tumors, according to a study
published in the November 5 edition of Breast Cancer
Research. The protective value of
p53 applies to both triple-negative and Her2-positive breast cancer.
No comments:
Post a Comment